Monge-Fuentes Victoria, Muehlmann Luis Alexandre, Longo João Paulo Figueiró, Silva Jaqueline Rodrigues, Fascineli Maria Luiza, de Souza Paulo, Faria Fernando, Degterev Igor Anatolievich, Rodriguez Anselmo, Carneiro Fabiana Pirani, Lucci Carolina Madeira, Escobar Patricia, Amorim Rivadávio Fernandes Batista, Azevedo Ricardo Bentes
Laboratory of Nanobiotechnology, Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brazil.
Laboratory of Applied Physics, Institute of Physics, University of Brasília, Brazil.
J Photochem Photobiol B. 2017 Jan;166:301-310. doi: 10.1016/j.jphotobiol.2016.12.002. Epub 2016 Dec 9.
Melanoma is the most aggressive and lethal form of skin cancer, responsible for >80% of deaths. Standard treatments for late-stage melanoma usually present poor results, leading to life-threatening side effects and low overall survival. Thus, it is necessary to rethink treatment strategies and design new tools for the treatment of this disease. On that ground, we hereby report the use of acai oil in nanoemulsion (NanoA) as a novel photosensitizer for photodynamic therapy (PDT) used to treat melanoma in in vitro and in vivo experimental models. NIH/3T3 normal cells and B16F10 melanoma cell lines were treated with PDT and presented 85% cell death for melanoma cells, while maintaining high viability in normal cells. Flow cytometry indicated that cell death occurred by late apoptosis/necrosis. Tumor bearing C57BL/6 mice treated five times with PDT using acai oil in nanoemulsion showed tumor volume reduction of 82% in comparison to control/tumor group. Necrotic tissue per tumor area reached its highest value in PDT-treated mice, supporting PDT efficacy. Overall, acai oil in nanoemulsion was an effective photosensitizer, representing a promising source of new photosensitizing molecules for PDT treatment of melanoma, a tumor with an inherent tendency to be refractory for this type of therapy.
黑色素瘤是皮肤癌中最具侵袭性和致命性的形式,导致超过80%的皮肤癌死亡。晚期黑色素瘤的标准治疗通常效果不佳,会产生危及生命的副作用且总体生存率较低。因此,有必要重新思考治疗策略并设计治疗该疾病的新工具。基于此,我们在此报告使用纳米乳剂中的阿萨伊油(NanoA)作为一种新型光敏剂用于光动力疗法(PDT),该疗法用于体外和体内实验模型中治疗黑色素瘤。用PDT处理NIH/3T3正常细胞和B16F10黑色素瘤细胞系,黑色素瘤细胞出现85%的细胞死亡,而正常细胞保持高活力。流式细胞术表明细胞死亡是由晚期凋亡/坏死引起的。用纳米乳剂中的阿萨伊油进行5次PDT处理的荷瘤C57BL/6小鼠与对照/肿瘤组相比,肿瘤体积减少了82%。每个肿瘤区域的坏死组织在接受PDT治疗的小鼠中达到最高值,支持了PDT的疗效。总体而言,纳米乳剂中的阿萨伊油是一种有效的光敏剂,是用于PDT治疗黑色素瘤的新光敏分子的有前景来源,黑色素瘤是一种本身就倾向于对这类治疗难治的肿瘤。